Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/16058
Title: SHORT COMMUNICATION Pattern of anti-tuberculosis drugs susceptibility in new and previously treated tuberculosis patients and environmental risk factors investigation
Authors: Salma Hameed
Nasir Mahmood
Chaudhry, Muhammad Nawaz
Sajid Rashid Ahmad
Mohammad Aqeel ur Rahman
Salma Hameed
Chaudhry, Muhammad Nawaz
Nasir Mahmood
Keywords: Mycobacterium tuberculosis
multi-drug resistance
drug susceptibility test
drug resistance
Issue Date: 2-Aug-2019
Publisher: Karachi: Faculty of Pharmacy & Pharmaceutical Sciences University of Karachi
Citation: Hameed, S., Mahmood, N., Chaudhry, M. N., Ahmad, S. R., & ur Rahman, M. A. (2019). Pattern of anti-tuberculosis drugs susceptibility in new and previously treated tuberculosis patients and environmental risk factors investigation. Pakistan Journal of Pharmaceutical Sciences, 32(4), 1709-1714.
Abstract: Resistance pattern both in newly and previously treated-TB patients and risk factors associated in spread of tuberculosis are investigated in the current study. A total 244 Mycobacterium tuberculosis isolates were used for drugsusceptibility test against four drugs. Environmental risk factors were assessed by using self-designed history proforma. Among 244 TB-isolates, 64% were categorized as MDR-TB in drug-susceptibility test. Male proportion was 51% while 32% belonged to 15-34 years age group and 49% were from city Lahore whereas majority of people (31%) was working on daily wages. Divergent drug-resistance pattern was obtained; RIF (68%), SM (52%), EMB (51%). INH showed only (27%) resistance against first-line anti-TB drug. Drug-resistance prevalence for two drug combination was highest (50%) for (INH+SM) and (INH+EMB) followed by (RIF+SM) (49%) whereas for three drugs combination (INH+RIF+EMB) and (INH+RIF+SM) the prevalence was almost same 50% and 49% respectively while 66% patients were categorized as previously treated and 34% as new TB cases. In drug susceptibility test, 71% were identified as MDR-TB among New TB cases, while 63% were identified as MDR-TB from previously treated cases. Surprisingly DST results displayed that percentage prevalence of MDR-TB both in newly and previously treated cases was almost same.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/16058
ISSN: 1011-601X
Appears in Collections:Issue 4

Files in This Item:
File Description SizeFormat 
Paper-33.htm131 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.